Corrigendum to 'Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience' [Leukemia Res. 114 (March 2022) 106803](S0145212622000297)(10.1016/j.leukres.2022.106803)

Authors :: De Bellis, E.
Imbergamo, S.
Candoni, A.
Lico, A.
Tanasi, I.
Mauro, E.
Mosna, F.
Leoncin, M.
Stulle, M.
Griguolo, D.
Pravato, S.
Trentin, L.
Lazzarotto, D.
Di Bona, E.
Sancetta, R.
Lucchini, E.
Poiani, M.
Palmieri, C.
Zaja, F.
Publication Year :: 2022
Publisher :: Elsevier Ltd, 2022.

Tools